NCT06146088View on ClinicalTrials.gov

Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

November 25, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

July 15, 2026

Conditions
Hand, Foot and Mouth Disease
Interventions
BIOLOGICAL

EV71 Vaccine

Inactivated enterovirus 71 vaccine (human diploid cell) of 3.0EU/0.5mL on Day 0,30

Trial Locations (4)

Unknown

NOT_YET_RECRUITING

Chencang Center for Disease Prevention and Control, Baoji

RECRUITING

Ningqiang Center for Disease Prevention and Control, Hanzhong

NOT_YET_RECRUITING

Fuping Center for Disease Prevention and Control, Weinan

RECRUITING

Jingyang Center for Disease Prevention and Control, Xianyang

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention, China

OTHER_GOV

lead

Institute of Medical Biology, Chinese Academy of Medical Sciences

OTHER